Allakos Market Cap

Aurobindo Pharma has a market cap or net worth of 605.25 billion as of August 8, 2025. Its market cap has decreased by -23.69% in one year.

Market Cap

605.25B

Enterprise Value

605.46B

Revenue

320.25B

Ranking

n/a

PE Ratio

17.85

Stock Price

$1,041.65

Market Cap Chart

Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 605.25B, an increase of 6,202.57%. That is a compound annual growth rate of 19.63%.

Market Cap History

Date	Market Cap	% Change
Aug 8, 2025	605.25B	-21.91%
Dec 31, 2024	775.08B	22.03%
Dec 29, 2023	635.16B	147.32%
Dec 30, 2022	256.82B	-40.31%
Dec 31, 2021	430.28B	-20.29%
Dec 31, 2020	539.83B	101.66%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Reliance Industries	18.51T
HDFC Bank	15.15T
Bharti Airtel	11.15T
Tata Consultancy Services	10.99T
ICICI Bank	10.25T
State Bank of India	7,424.82B
Infosys	5,899.00B
Hindustan Unilever	5,870.69B

Market Cap Rankings